{
  "documentMetadata": {
    "title": "Necrotizing Fasciitis, Staph. aureus",
    "lastUpdated": "2023-04-22",
    "sourceFile": "Necrotizing Fasciitis, Staph. aureus.pdf"
  },
  "content": [
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Clinical Setting"
        },
        {
          "type": "list",
          "items": [
            "Skin infection due to community-acquired methicillin-resistant Staph. aureus (CA-MRSA).",
            "Infection extends into the fascial plane between muscle and subcutaneous fat with resulting necrotizing fasciitis."
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Etiologies"
        },
        {
          "type": "list",
          "items": [
            "Staphylococcus aureus (CA-MRSA)"
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Primary Regimens"
        },
        {
          "type": "list",
          "items": [
            "Incision for exploration, drainage and debridement"
          ]
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Vancomycin",
                "dose": "15-20 mg/kg",
                "route": "IV q8-12h",
                "notes": "to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator); alternative is trough of 15-20 µg/mL"
              }
            ]
          }
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Alternative Regimens"
        },
        {
          "type": "list",
          "items": [
            "Incision for exploration, drainage and debridement"
          ]
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Daptomycin",
                "dose": "4-6 mg/kg",
                "route": "IV q24h"
              }
            ]
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Telavancin",
                "dose": "10 mg/kg",
                "route": "IV q24h"
              }
            ]
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Linezolid",
                "dose": "600 mg",
                "route": "IV q12h"
              }
            ]
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Clindamycin",
                "dose": "900 mg",
                "route": "IV q8h",
                "notes": "is sometimes added to initial regimen as adjunct to inhibit protein (toxin) synthesis (which can occur if organism is susceptible; not needed if Linezolid is used as this is a protein synthesis inhibitor)."
              }
            ]
          }
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Antimicrobial Stewardship"
        },
        {
          "type": "list",
          "items": [
            "Empiric regimens should include gram-negative and anaerobic coverage in addition to the above, until pathogen identified. Then, switch to targeted therapy."
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Comments"
        },
        {
          "type": "list",
          "items": [
            "Historically, Staph. aureus was not associated with necrotizing fasciitis, but community-acquired MRSA is different and can cause the disease.",
            "See Necrotizing Fasciitis, Overview for further discussion and links to other etiologies.."
          ]
        }
      ]
    }
  ]
}
